Please provide your email address to receive an email when new articles are posted on . An upgrade in YAG laser technology may be a breakthrough in the management of ...

Please provide your email address to receive an email when new articles are posted on . Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a joint society of cornea, cataract and ...

SAN DIEGO -- Laser treatment for eye floaters fell short of expectations, as the intervention improved patient-perceived floater burden but not intraocular pressure (IOP) or visual acuity, a ...

Pharmacological vitreolysis is a promising development in the management of vitreoretinal interface-related disorders, especially because other treatment options have potentially significant drawbacks ...

Stalmans et al. (Aug. 16 issue) 1 report that intravitreal injection of ocriplasmin was superior to injection of placebo in altering the vitreoretinal interface of affected eyes. It was associated ...

The option of Nd:YAG vitreolysis as a strategy to attenuate troublesome floaters, as proposed by Larry Benjamin and colleagues, 1 is an attractive proposition. Posterior vitreous detachment in ...

YAG laser vitreolysis effectively treated symptomatic vitreous floaters, according to a report published in the September issue of JAMA Ophthalmology. Posterior vitreous detachment occurs in 65% of ...

Inceptua – pharmaceutical company and service partner – and biopharmaceutical company Oxurion have announced a global license agreement for the commercialization of JETREA®, a first-in-class ...

ThromboGenics Announces Publication of New England Journal of Medicine Paper Entitled "Enzymatic Vitreolysis with Ocriplasmin for Vitreomacular Traction and Macular Holes" LEUVEN, Belgium, August 15, ...

Dr. Scott Geller is playing Space Invaders with my vision, aiming a high powered (and very real) laser beam into my eyes to “pulverize” the floaters that have made my life an optical misery following ...